Researchers at Israel’s Technion have developed an AI system that identified 77 approved cancer nano-therapies that can chemically self-assemble in nearly 2,000 combinations to be far more effective, with less side-effects. They proved their system, combining bortezomib-cabozantinib to treat head/neck cancer.

https://nocamels.com/2023/09/new-ai-tool-combines-cancer-drugs-to-optimize-treatment/

https://www.israel21c.org/ai-matchmaker-heralds-new-era-in-nano-cancer-treatment/

https://www.sciencedirect.com/science/article/abs/pii/S0168365923004236?dgcid=author